FDA Official Details Hurdles to Biomarker Development

Drug Industry Daily
A A
CDER Director Janet Woodcock is calling on industry to collaborate in the development and verification of new biomarkers, which the agency says can improve clinical trial efficiency but so far have been underused.

To View This Article:

Login

Subscribe To Drug Industry Daily